Palleon Pharmaceuticals reports Phase I/II trial results of E-602 for solid tumours
The study involved 21 participants with various anti-PD-(L)1-resistant solid tumours.
Clinical Trials
OncoResponse reports data from Phase I solid tumour treatment trial
Averitas completes recruitment for trial of QUTENZA to treat post-surgical pain
Radella reports positive outcomes from trial of MD-18 for obesity and diabetes
Minghui Pharmaceutical’s MHB039A shows promise in Phase I trial for solid tumours
Senhwa enrols first subject in Phase I/II trial of silmitasertib for solid tumours
Ionis announces design for Phase III trial of Angelman syndrome therapy
Zymeworks doses first subject in Phase I trial of ZW191 for solid tumours
